Please recommend a suitable primary liver cell cryopreservation solution, as it is too expensive to import and has a long lead time

For primary hepatocyte cryopreservation solution, you shouldn't only look at post-thaw viability—attachment rate and metabolic enzyme activity are the key factors. It is recommended to first ask the manufacturer to provide primary human hepatocyte data, preferably including albumin secretion and CYP1A2/3A4 activity comparisons, rather than only providing hepatoma cell line data. Within a budget of 1200, there are domestic options, but you must request small-pack trial samples, such as 20–50 ml. After receiving them, perform a head-to-head comparison: divide hepatocytes from the same donor into two aliquots, use your original imported solution for one and the domestic solution for the other, cryopreserve and thaw them in parallel, and measure 24 h attachment rate, morphological spreading, and CYP enzyme activity. Switch only if the differences are acceptable—don't directly buy large bottles.

When looking for domestic alternatives, besides price, the supply chain must be stable. Primary hepatocytes are hard to obtain, and stockouts or batch-to-batch variability can severely affect experiments. It is recommended to screen two suppliers and request COA, endotoxin, sterility, pH, osmolality, and animal-origin-free statements from each, and confirm that they have stock and can ship within 3 days. Cryopreservation of primary human hepatocytes is sensitive to density, cooling rate, and resuscitation procedures. After changing the medium, first optimize with a small sample; do not use all the cells with the new medium. If conducting metabolic enzyme research, additionally test CYP induction activity, preferably in parallel with the imported medium. Theoretically, a 100 ml specification can be found within a budget of 1200, but it is recommended to start with a small package.

We have produced primary liver cells before, and replacing them with domestic cryopreservation solution is not impossible, but we need to leave enough time for validation. Suggest requesting manufacturers to provide data on the adhesion rate and metabolic enzyme indicators of primary liver cells after cryopreservation, and apply for samples. After receiving the goods, inspect the appearance and COA, and divide them into small volumes to avoid repeated freezing and thawing. In practical operation, the freezing density, program cooling rate, and recovery dilution method have a significant impact on the adhesion rate, and need to be re optimized after fluid change. If you are producing primary liver cells for a long time, it is recommended to have a domestic supplier and keep imported ones as key batch controls. Find a 100ml specification within the budget, and it's best to discuss the policy of purchasing larger bottles after a satisfactory trial.

Importing is too expensive and the long lead time is indeed inconvenient for primary generation experiments. Domestic substitutes can be found specifically for primary liver cells rather than universal serum-free ones, and the formula design is more inclined towards maintaining liver cell function. When making a purchase, ask whether there are no animal sources, DMSO content, and whether there are growth factors or extracellular matrix components. The small package trial policy is very important, and many domestic manufacturers are willing to provide it, but may need to bear the shipping cost or submit trial feedback. Our laboratory has previously used a domestically produced small package with activity and adhesion rates similar to imports, but there are significant individual differences in CYP enzyme activity that require validation on a batch by batch basis. So it is recommended to maintain the same donor control.